Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001209191-23-008218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-09 | 2023-02-07 | DLB | TEVANIAN AVADIS | Dir | A - Grant | $0.00 | +3,296 | 3,296 | New | $0 | |
| I | 2023-02-09 | 2023-02-07 | DLB | TEVANIAN AVADIS | Dir | S - Sale | $83.64 | -1,392 | 53.3K | -3% | -$116.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-07 | A | A | 3,296 | $0.00 | 3,296 | D By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996 | — | — | (F1) Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. (F2) Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. |
| 2 | Common | Class A Common Stock | 2023-02-07 | S | D | 1,392 | $83.64 | 53,282 | I | — | — |